Locations:
Search IconSearch

Cancer Advances

Cleveland Clinic's Cancer Institute is proud to share top highlights from 2024

Tumor-Infiltrating Lymphocytes (TIL) therapy

Tumor-Infiltrating Lymphocytes Therapy Now Available for Treating Unresectable or Metastatic Melanoma

Cleveland Clinic Cancer Institute among select group of centers to administer highly personalized treatment

Advertisement

Innovations and Emerging Therapies

ovarian cancer
Robotic Cytoreductive Surgery with Laparoscopic HIPEC for Ovarian Cancer

Surgeons at Cleveland Clinic Weston Hospital demonstrate the latest approaches to treating gynecological cancer

IBM Quantum Computer
Two Studies Show Potential of a Molecular Biomarker to Improve Lung Cancer Screening

Quantum computing being studied as a means to help improve predictive performance, accuracy

Scrambler therapy for nerve pain
Scrambler Technology Life Changing for Many Patients with Neuropathic Pain

Novel therapy “retrains” the brain to disrupt pain signals

Dr. Dermawan
New Genomic Models for Leiomyosarcoma Treatment (Podcast)

Soft tissue pathologist discusses research into incorporating genomic data to improve risk stratification

Rare Diseases

Hereditary Hemorrhagic Telangiectasia
Pomalidomide Effective in Treating Hereditary Hemorrhagic Telangiectasia

Oral medication reduces epistaxis and improves quality of life for patients with rare vascular disorder

Genetic sequencing
AI Can Help Find Trials for Patients with Rare Cancers

Study demonstrates potential for improving access

Research Insights

Reviewing dental scans
A Call for More Interdisciplinary and Preventive Care in New Osteoradionecrosis Guidelines

New guidelines offer insight into emerging therapies, dental issues and more

viral-induced cancer
Mechanism of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) May Serve as Clue to More Effective Treatment

Cleveland Clinic researchers discover what drives – and what may halt – virus-induced cancer

Dr. Shilpa Gupta
New Studies Reinforce Benefits of Combination Treatment for Urothelial Carcinoma

Enfortumab vedotin plus pembrolizumab benefited patients, regardless of biomarker expression

Access and Equity in Cancer Care

Director of the Novel Cancer Therapeutics Center
Oncology Pharmacovigilance Clinic Expands Specialties

First-of-its-kind clinic for immune-related adverse events supports oncologists in managing severe side effects

Young patient with cancer
Multidisciplinary Care Model Supports Young People with Cancer

Integrated program addresses growing need for comprehensive cancer care among adolescents, young adults and adults under 50 with early onset cancers

Dr. Grobmyer and team
Fatima bint Mubarak Center Improves Access to Emerging Therapies and Clinical Trials

Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates

Resources

Advertisement